Let's talk medical research

At any given time, there are hundreds of thousands of research studies listed on ClinicalTrials.gov actively looking for patients both in the United States and across the globe. However, the multitude of options available does not necessarily mean it’s easy for interested individuals to find opportunities they are eligible for. That’s why we created Antidote Match™, a clinical trial search tool ...

Enrolling patients in clinical trials requires more than just effective outreach strategies. Even with strong recruitment, delays at the site level may cause potential participants to lose interest, while overwhelming sites with low-quality referrals can waste valuable time and resources.

Interactive Web Response Systems (IWRS) and Interactive Voice Response Systems (IVRS) are technologies used by research sites to manage patient enrollment, patient randomization, and study drug supplies. Collectively, these technologies can be referred to as Interactive Response Technologies (IRTs) or Randomization and Trial Supply Management (RTSM). These systems are a critical piece of every ...

The annual Kidney Action Week is a virtual event put on by the American Kidney Fund designed to bring the entire kidney health community together for a week of amazing and informative content on all things related to kidney health. The event is filled with discussions, Q&As, webinars, and more — and this year, Antidote was thrilled to be involved!

Each year in March, the National Institute of Diabetes and Digestive and Kidney Diseases puts on National Kidney Month, a month dedicated to raising awareness about kidney health and conditions. Chronic kidney disease, a grouping of conditions that damage the kidneys, impacts around 37 million Americans, and millions of others are considered to be at an increased risk.

The rare, inherited blood disorder hemophilia is estimated to impact approximately 20,000 individuals in the United States, and over 400,000 worldwide. Currently, there is no cure for hemophilia — but through ongoing research, medical experts are continually learning more about the disease.

Depression, also known as clinical depression, Major Depressive Disorder, or MDD, is estimated to impact one out of six adults at some point in their lifetime, making it one of the most common mental disorders in the United States. It is estimated that the cost of depression totals $100 billion annually. While there are treatments available, finding the optimal one can place a significant burden ...

Hepatitis B, sometimes abbreviated to HBV, is a liver infection that is one of the most serious in the world. If left untreated, hepatitis B can cause fibrosis, cirrhosis, hepatocellular carcinoma, and end-stage liver disease.

Before any new medication, therapy, or treatment is put onto the market, it must first be approved by the Food and Drug Administration. Part of this approval process is thorough testing through clinical trials to ensure that any therapy is safe and effective before it is released to the general public.

Idiopathic pulmonary fibrosis, or IPF, can be a frightening diagnosis. IPF is a rare, progressive lung disease that develops differently for everyone, and managing its development can be difficult. However, some individuals are able to live with the disease and stay active for many years.